CHEK2 and breast cancer: A recent example of such an approach has been seen with the identification of the CHEK2 S428F mutation in the Ashkenazi Jewish population, which has been associated with a relative breast cancer risk of 2.0 amongst Ashkenazi Jewish women [14].